Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Reversine |
Synonyms | |
Therapy Description |
Reversine is an A3 adenosine receptor antagonist and pan-Aurora kinase and TTK (MPS1) inhibitor, which prevents cell proliferation (PMID: 14719906, PMID: 18483302, PMID: 25043312, PMID: 32857324). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Reversine | AURK Inhibitor (Pan) 12 MPS1 Inhibitor 27 | Reversine is an A3 adenosine receptor antagonist and pan-Aurora kinase and TTK (MPS1) inhibitor, which prevents cell proliferation (PMID: 14719906, PMID: 18483302, PMID: 25043312, PMID: 32857324). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|